Buying and label claims

This drawer is about the paperwork rather than the molecule: what "research use only" means, how to read a purity certificate, why approved tirzepatide pens need no reconstitution chart, how syringe units differ from milligrams, what tesamorelin really costs, and why before and after galleries rank below trial data.

These files matter because many harms come from the product and the arithmetic, not the peptide itself: a wrong concentration, a mix-up between units and milligrams, contamination, or a label that states a mass but proves nothing about identity. Each case points to the regulator records behind it, including FDA warnings about dosing errors with compounded injections. Start with the peptide dosing chart built only from approved labels, or the glossary of label terms.